Apexigen Inc.

NASDAQ: APGN · Real-Time Price · USD
0.39
0.04 (9.86%)
At close: Aug 22, 2023, 9:59 PM

Apexigen Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a
Cost of Revenue
n/a n/a
Gross Profit
n/a n/a
Operating Income
-32.69M -28.96M
Interest Income
n/a 41K
Pretax Income
-32.07M -28.92M
Net Income
-31.45M -28.88M
Selling & General & Admin
9.65M 7.29M
Research & Development
23.04M 21.66M
Other Expenses
617K n/a
Operating Expenses
32.69M 28.96M
Interest Expense
-617K n/a
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
32.69M 28.96M
Income Tax Expense
-617K -41K
Shares Outstanding (Basic)
19.79M 31.07M
Shares Outstanding (Diluted)
19.79M 31.07M
EPS (Basic)
-1.59 -0.93
EPS (Diluted)
-1.59 -0.93
EBITDA
-32.58M -28.85M
EBIT
n/a n/a
Depreciation & Amortization
110K 105K